Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. We are initially focusing our product development efforts in Sickle Cell Disease, a genetic disorder. Our lead product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in our completed Phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.
View Top Employees from Emmaus Life Sciences, IncWebsite | http://www.emmausmedical.com/default.aspx |
Revenue | $15 million |
Funding | $79.5 million |
Employees | 49 (46 on RocketReach) |
Founded | 2000 |
Address | 21250 Hawthorne Blvd, Torrance, California 90503, US |
Phone | (310) 214-0065 |
Fax | (310) 214-0075 |
Technologies |
JavaScript,
HTML,
Twitter
+17 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Hospitals & Clinics, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Health Diagnostics, Life Science, Pharmaceutical |
Web Rank | 8 Million |
Keywords | Emmaus Life Sciences, Yutaka Niihara Md, Emmauslifesciences, Zorbtive, Endari |
Competitors | Amryt Pharma, Cerecor, Inc., Corcept Therapeutics, MediQuest Therapeutics, Inc., Otonomy, Inc |
SIC | SIC Code 809 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 62 Companies, NAICS Code 621 Companies, NAICS Code 621498 Companies, NAICS Code 62149 Companies, NAICS Code 6214 Companies, NAICS Code 62139 Companies |
Looking for a particular Emmaus Life Sciences, Inc employee's phone or email?
The Emmaus Life Sciences, Inc annual revenue was $15 million in 2024.
Yasushi Nagasaki is the CFO of Emmaus Life Sciences, Inc.
46 people are employed at Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc is based in Torrance, California.
The NAICS codes for Emmaus Life Sciences, Inc are [6213, 621399, 62, 621, 621498, 62149, 6214, 62139].
The SIC codes for Emmaus Life Sciences, Inc are [809, 80].